CDKN1A and hepatocellular carcinoma: on the other side, we found that miR-182-5p targets number of cell cycle and HCC development genes as CDKN1A, BCL2, and CDKN1B in vital pathways including HIF-1 signaling pathway, P53 signaling pathway, cell cycle and JAK-STAT signaling pathway (48).